Validation of a Novel Nomogram for Prediction of Local Relapse after Surgery for Invasive Breast Carcinoma

被引:23
作者
Corso, Giovanni [1 ,2 ]
Maisonneuve, Patrick [3 ]
Massari, Giulia [1 ]
Invento, Alessandra [1 ]
Pravettoni, Gabriella [2 ,4 ]
De Scalzi, Alessandra [1 ]
Intra, Mattia [1 ]
Galimberti, Viviana [1 ]
Morigi, Consuelo [1 ]
Lauretta, Milena [1 ]
Sacchini, Virgilio [2 ,5 ]
Veronesi, Paolo [1 ,2 ]
机构
[1] IEO European Inst Oncol IRCCS, Div Breast Surg, Milan, Italy
[2] Univ Milan, Fac Med, Milan, Italy
[3] IEO European Inst Oncol IRCCS, Div Epidemiol & Biostat, Milan, Italy
[4] IEO European Inst Oncol IRCCS, Appl Res Div Cognit & Psychol Sci, Milan, Italy
[5] Mem Sloan Kettering Canc Ctr, Dept Surg, Breast Serv, New York, NY 10021 USA
关键词
PATHOLOGICAL COMPLETE RESPONSE; SURGICAL ADJUVANT BREAST; POSITIVE SENTINEL NODE; PREOPERATIVE CHEMOTHERAPY; CONSERVING SURGERY; ESTROGEN-RECEPTOR; CANCER PATIENTS; FREE SURVIVAL; RECURRENCE; RISK;
D O I
10.1245/s10434-019-08160-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Around 7% of women who undergo breast-conserving surgery (BCS) or mastectomy are at risk of developing ipsilateral breast tumor recurrence (IBTR). When assessing risks that, like that of IBTR, depend on multiple clinicopathological variables, nomograms are the predictive tools of choice. In this study, two independent nomograms were constructed to estimate the individualized risk of IBTR after breast surgery. Patients and Methods In this retrospective study, 18,717 consecutive patients with primary invasive breast cancer were enrolled. The training set used for building the nomograms comprised 15,124 patients (11,627 treated with BCS and 3497 with mastectomy), while the validation set included 3593 women (2565 BCS and 1028 mastectomy). Median follow-up time was 8 years in the training set and 6 years in the validation set. Multivariable Cox proportional hazards regression was used to identify independent factors for IBTR. Two separated nomograms were constructed on multivariate models for BCS and mastectomy. Results The factors that associated with IBTR after either BCS or mastectomy were identified. The two multivariable models were used to build nomograms for the prediction of IBTR 1 year, 5 years, and 10 years after BCS or after mastectomy. Five-year and 10-year IBTR rates in the BCS training set were equal to 3.50% and 7.00%, respectively, and to 5.39% and 7.94% in the mastectomy training set. The nomograms were subsequently validated with c-index values of 0.77 and 0.69 in the BCS and mastectomy validation sets, respectively. Conclusions The nomograms presented in this study provide clinicians and patients with a valuable decision-making tool for choosing between different treatment options for invasive breast cancer.
引用
收藏
页码:1864 / 1874
页数:11
相关论文
共 30 条
[1]   Increased Risk of Locoregional Recurrence for Women With T1-2N0 Triple-Negative Breast Cancer Treated With Modified Radical Mastectomy Without Adjuvant Radiation Therapy Compared With Breast-Conserving Therapy [J].
Abdulkarim, Bassam S. ;
Cuartero, Julie ;
Hanson, John ;
Deschenes, Jean ;
Lesniak, David ;
Sabri, Siham .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (21) :2852-2858
[2]   Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation [J].
Bevilacqua, Jose Luiz B. ;
Kattan, Michael W. ;
Fey, Jane V. ;
Cody, Hiram S., III ;
Borgen, Patrick I. ;
Van Zee, Kimberly J. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (24) :3670-3679
[3]   Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas [J].
Brennan, MF ;
Kattan, MW ;
Klimstra, D ;
Conlon, K .
ANNALS OF SURGERY, 2004, 240 (02) :293-298
[4]   A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancer [J].
Colleoni, M. ;
Bagnardi, V. ;
Rotmensz, N. ;
Dellapasqua, S. ;
Viale, G. ;
Pruneri, G. ;
Veronesi, P. ;
Torrisi, R. ;
Luini, A. ;
Intra, M. ;
Galimberti, V. ;
Montagna, E. ;
Goldhirsch, A. .
ANNALS OF ONCOLOGY, 2009, 20 (07) :1178-1184
[5]   Ipsilateral Breast Tumor Reappearance and Contralateral Breast Cancer after Primary Breast Cancer Treatment: A Comprehensive Retrospective Study of 15,168 Patients [J].
Corso, Giovanni ;
Maisonneuve, Patrick ;
Santomauro, Giorgia Irene ;
De Scalzi, Alessandra Margherita ;
Toesca, Antonio ;
Bassi, Fabio Domenico ;
Farante, Gabriel ;
Caldarella, Pietro ;
Intra, Mattia ;
Galimberti, Viviana ;
Veronesi, Paolo .
ONCOLOGY, 2018, 95 (03) :147-155
[6]  
Ellis, 2003, INT AGENCY RES CANC, V5, P13
[7]  
Elston C W, 2002, Histopathology, V41, P154
[8]   PATHOLOGICAL PROGNOSTIC FACTORS IN BREAST-CANCER .1. THE VALUE OF HISTOLOGICAL GRADE IN BREAST-CANCER - EXPERIENCE FROM A LARGE STUDY WITH LONG-TERM FOLLOW-UP [J].
ELSTON, CW ;
ELLIS, IO .
HISTOPATHOLOGY, 1991, 19 (05) :403-410
[9]   Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: Eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil [J].
Fisher, B ;
Dignam, J ;
Mamounas, EP ;
Costantino, JP ;
Wickerham, DL ;
Redmond, C ;
Wolmark, N ;
Dimitrov, NV ;
Bowman, DM ;
Glass, AG ;
Atkins, JN ;
Abramson, N ;
Sutherland, CM ;
Aron, BS ;
Margolese, RG .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (07) :1982-1992
[10]  
Fisher B, 1996, NEW ENGL J MED, V334, P987